Apolipoprotein AI (ApoA-I), immunity, inflammation and cancer
K Georgila, D Vyrla, E Drakos - Cancers, 2019 - mdpi.com
Apolipoprotein AI (ApoA-I), the major protein component of high-density lipoproteins (HDL)
is a multifunctional protein, involved in cholesterol traffic and inflammatory and immune …
is a multifunctional protein, involved in cholesterol traffic and inflammatory and immune …
Protein disulfide isomerase: a promising target for cancer therapy
S Xu, S Sankar, N Neamati - Drug discovery today, 2014 - Elsevier
Highlights•PDI is an important oxidase, reductase, isomerase and molecular
chaperone.•PDI expression is up-regulated in select types of cancers.•Silencing PDI results …
chaperone.•PDI expression is up-regulated in select types of cancers.•Silencing PDI results …
Protein disulfide isomerase in redox cell signaling and homeostasis
FRM Laurindo, LA Pescatore… - Free Radical Biology and …, 2012 - Elsevier
Thiol proteins may potentially act as redox signaling adaptor proteins, adjusting reactive
oxygen species intermediates to specific signals and redox signals to cell homeostasis. In …
oxygen species intermediates to specific signals and redox signals to cell homeostasis. In …
Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression
Prostate cancer is the most common malignancy and the second leading cause of cancer-
related deaths in men. One common treatment is androgen-deprivation therapy, which …
related deaths in men. One common treatment is androgen-deprivation therapy, which …
Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer
K Davalieva, IM Kostovska, S Kiprijanovska… - The …, 2015 - Wiley Online Library
BACKGROUND The key to a more effective diagnosis, prognosis, and therapeutic
management of prostate cancer (PCa) could lie in the direct analysis of cancer tissue. In this …
management of prostate cancer (PCa) could lie in the direct analysis of cancer tissue. In this …
[HTML][HTML] Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery
The clinical and fundamental research in prostate cancer-the most common urological
cancer in men-is currently entering the proteomic and genomic era. The focus has switched …
cancer in men-is currently entering the proteomic and genomic era. The focus has switched …
Database-augmented mass spectrometry analysis of exosomes identifies claudin 3 as a putative prostate cancer biomarker
TS Worst, J Von Hardenberg, JC Gross, P Erben… - Molecular & Cellular …, 2017 - ASBMB
In prostate cancer and other malignancies sensitive and robust biomarkers are lacking or
have relevant limitations. Prostate specific antigen (PSA), the only biomarker widely used in …
have relevant limitations. Prostate specific antigen (PSA), the only biomarker widely used in …
Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer
K Davalieva, S Kiprijanovska, S Komina… - Proteome science, 2015 - Springer
Despite the overall success of prostate specific antigen (PSA) in screening and detection of
prostate cancer (PCa), its use has been limited due to the lack of specificity. The principal …
prostate cancer (PCa), its use has been limited due to the lack of specificity. The principal …
Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant …
Androgen deprivation constitutes the principal therapy for advanced and metastatic prostate
cancers. However, this therapeutic intervention usually results in the transition to a more …
cancers. However, this therapeutic intervention usually results in the transition to a more …
The role of proteomics in prostate cancer research: biomarker discovery and validation
PURPOSE: Prostate Cancer (PCa) represents the second most frequent type of tumor in
men worldwide. Incidence increases with patient age and represents the most important risk …
men worldwide. Incidence increases with patient age and represents the most important risk …